HPC
ABBV icon

Hobart Private Capital’s AbbVie ABBV Stock Holding History

Hobart Private Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Sell
1,511
-77
-5% -$16.6K 0.07% 110
2026
Q1 		$345K Sell
1,588
-26
-2% -$5.77K 0.07% 99
2025
Q4 		$369K Buy
1,614
+487
+43% +$111K 0.07% 101
2025
Q3 		$261K Buy
1,127
+48
+4% +$9.78K 0.05% 108
2025
Q2 		$200K Buy
+1,079
New +$201K 0.05% 112
2021
Q4 		– Sell
-6,653
Closed -$718K – 42
2021
Q3 		$718K Sell
6,653
-2,913
-30% -$333K 0.28% 46
2021
Q2 		$1.08M Sell
9,566
-315
-3% -$35.5K 0.44% 26
2021
Q1 		$1.07M Sell
9,881
-679
-6% -$72.6K 0.44% 28
2020
Q4 		$1.13M Sell
10,560
-835
-7% -$80.2K 0.5% 26
2020
Q3 		$998K Sell
11,395
-6,288
-36% -$592K 0.51% 29
2020
Q2 		$1.74M Sell
17,683
-6,303
-26% -$555K 0.98% 20
2020
Q1 		$1.83M Sell
23,986
-602
-2% -$51.3K 1.25% 17
2019
Q4 		$2.18M Buy
24,588
+1,083
+5% +$89.9K 1.33% 15
2019
Q3 		$1.78M Buy
23,505
+3,282
+16% +$225K 1.21% 17
2019
Q2 		$1.47M Buy
20,223
+1,236
+7% +$97.1K 1.02% 25
2019
Q1 		$1.53M Sell
18,987
-1,171
-6% -$95.8K 1.16% 24
2018
Q4 		$1.86M Buy
20,158
+12,771
+173% +$1.12M 1.59% 15
2018
Q3 		$699K Sell
7,387
-15
-0.2% -$1.42K 0.54% 53
2018
Q2 		$686K Sell
7,402
-3,629
-33% -$354K 0.56% 57
2018
Q1 		$1.04M Sell
11,031
-6,805
-38% -$748K 0.92% 40
2017
Q4 		$1.72M Buy
+17,836
New +$1.68M 1.54% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hobart Private Capital's ABBV Position: Q2 2026 in Review

Hobart Private Capital reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $16.6K and leaving 1,511 shares worth $380K. The position accounts for 0.07% of the portfolio, ranked #110.

Hobart Private Capital first reported a position in ABBV in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.18M in Q4 2019. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hobart Private Capital held 1,511 shares of AbbVie worth $380K as of Q2 2026.
  • Hobart Private Capital sold 77 AbbVie shares in Q2 2026, an estimated $16.6K.
  • AbbVie made up 0.07% of Hobart Private Capital's portfolio in Q2 2026, its #110 holding.
  • Hobart Private Capital first reported a position in AbbVie in Q4 2017 and has held it in 21 quarters since.
  • Hobart Private Capital's AbbVie position peaked at $2.18M in Q4 2019.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hobart Private Capital's 13F filing for Q2 2026, filed 6 Jul 2026.